FDA Extends Comment Period on Combination Products Rule

Washington Drug Letter
A A
Requests from stakeholders have led the FDA to extend the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00